Anglo American has published its seventh annual Tax and Economic Contribution Report, with a
detailed breakdown of the companyâs contributions across all its major operating jurisdictions,
amounting to more than $25 billion in 2020.
Mark Cutifani, Chief Executive of Anglo American, said: ‘Our annual Tax and Economic
Contribution Report helps our stakeholders more fully understand the breadth of our role in
society. The enduring positive impact of a business can only be properly assessed when you
consider the total footprint of its contributions. It is with this transparency that we seek to build
trust as a corporate leader in our industry â a key pillar of our Sustainable Mining Plan.
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, announces its results for the year ended 31 December 2020.
• Demonstrated that HEMO-CAR-T cells are effective against Acute Myloid Leukemia in vitro and in vivo • Developed a novel cell-based platform technology, referred to as CBR, for the treatment of emerging viral diseases, including COVID-19, as well as certain types of cancer
Sanne, a leading global provider of alternative asset and corporate services, announces that on 29 April 2021 awards over ordinary shares of 0.01p each in the Company were made to certain persons discharging managerial responsibilities (PDMRs). The following PDMRs were awarded ordinary shares under the Company s 2021 PSP with a grant date of 29 April 2021: Martin Schnaier; James Ireland; James Bermingham; Jason Bingham; Andrew Jones; Kevin Lazeris; Marie Measures; Peter Nagle; and Cindy Peters. No consideration was paid for the grant of the awards which are structured as conditional share awards. The vesting of an award is subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company. The awards will normally vest on the later of the third anniversary of grant and the determination of the performance conditions. The shares awarded to Martin Schnaier an
About Playtech Founded in 1999 and premium listed on the Main Market of the London Stock Exchange, Playtech is a market leader in the gambling and financial trading industries with c.6,400 employees across 24 countries. Playtech is the gambling industry s leading technology company delivering business intelligence driven gambling software, services, content and platform technology across the industry s most popular product verticals, including, casino, live casino, sports betting, virtual sports, bingo and poker. It is the pioneer of omni-channel gambling technology through its integrated platform technology, Playtech ONE. Playtech ONE delivers data driven marketing expertise, single wallet functionality, CRM and responsible gambling solutions across one single platform across product verticals and across retail and online.